Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.
about
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic SubstrateEffect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial.Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment ParallelsClinical Phenotypes in Heart Failure With Preserved Ejection FractionEarly life predictors of atrial fibrillation-related mortality: evidence from the health and retirement studyClinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study.A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation.Upregulation of sestrins protect atriums against oxidative damage and fibrosis in human and experimental atrial fibrillation.Galectin 3 and incident atrial fibrillation in the community.Birth weight and the risk of atrial fibrillation in whites and African Americans: the Atherosclerosis Risk In Communities (ARIC) study.Scarcity of atrial fibrillation in a traditional African population: a community-based study.Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarinLow-dose lacosamide-induced atrial fibrillation: Case analysis with literature reviewUsefulness of a low CHADS2 or CHA2DS2-VASc score to predict normal diagnostic testing in emergency department patients with an acute exacerbation of previously diagnosed atrial fibrillationGenetic loci associated with atrial fibrillation: relation to left atrial structure in the Framingham Heart Study.Obesity begets atrial fibrillation: a contemporary summaryA Non-Surgeon's Guide to Surgical Management of Atrial Fibrillation.Atrial fibrillation in Indigenous and non-Indigenous Australians: a cross-sectional study.Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort.Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study.Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke.A minimally invasive Cox maze IV procedure is as effective as sternotomy while decreasing major morbidity and hospital stay.Common and rare variants in SCN10A modulate the risk of atrial fibrillation.Angiotensin-converting enzyme-2 overexpression improves atrial remodeling and function in a canine model of atrial fibrillationHigh-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010.Rationale and design of the Chinese Atrial Fibrillation Registry Study.Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults.Race-specific impact of atrial fibrillation risk factors in blacks and whites in the southern community cohort study.N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials.High familial risk of atrial fibrillation/atrial flutter in multiplex families: a nationwide family study in SwedenPrediction of Atrial Fibrillation in a Racially Diverse Cohort: The Multi-Ethnic Study of Atherosclerosis (MESA)Impact of an Emergency Department Observation Unit Management Algorithm for Atrial Fibrillation.The Connection between Cardiac and Mental Disorder: Atrial Fibrillation in Patients with Psychiatric Disorder.Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition studyAn update on the prognosis of patients with atrial fibrillation.Atrial fibrillation in heart failure: The sword of Damocles revisited.Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making?
P2860
Q26799163-E52FA971-8668-47E3-8C21-6AB019BEA3E5Q27334353-3058291A-1D95-474F-BC66-C1729E7D88F6Q28067128-2C82E914-627D-42D5-8C9B-09689E0B5B98Q28073079-7A62AE88-8F15-46DE-A5BF-B6BA13ABEB3EQ28397562-0E6C8800-8A72-4BE5-AE8A-15955C0BBCFCQ31160340-A924AEA4-A63E-400B-B7E4-136ACA9CD8E2Q33439247-5300CBA9-AE08-4744-B3ED-553144061724Q33551782-3FB34732-0061-4EF4-B7E3-DFC71D24EE98Q33555143-02800A13-8FAA-44AC-B98E-1F657180696BQ33712264-B33DB373-3006-465F-A3C3-4881AC1F3521Q33936957-F170308D-6994-4707-80A9-0FF2A1D07F83Q33977604-C6AB5556-1C6A-4482-B3F9-5FBA0987B2E8Q34114744-3FD9B7E8-0B55-4666-AE02-889FC70C0DFEQ34163339-6E2313ED-013A-4372-95C9-4C67684A26D8Q34297198-70A01F80-DF08-4040-84BC-F672354D57DEQ34359251-96E65165-F451-4EB0-A472-6CF035B27A67Q34398295-65AB8333-B41D-4338-B10D-8DE09D773F0FQ34417212-168B6FCB-C8B1-458A-9960-2336E9C4F2BBQ34479088-36C9D6C3-6E14-4C39-8211-EA4274ACCEEEQ34921180-653382B3-6D49-497B-94CA-EB6EABD8B982Q35021951-0B714225-228C-4590-A1FE-5A2E2C1DDBF8Q35062047-EA847EA4-19BF-49F0-A488-29C24806C1DDQ35136427-1FAE74C0-F217-495B-975B-3F4905F1C0C8Q35180115-A1FC8450-5AF7-4AAB-B9E2-0084170BE606Q35352846-4F1EA5D5-B2EB-436B-A969-F5E620E494D2Q35354025-14C1B844-D5EF-4357-B736-A51FB3F65B57Q35599099-8C00E8DD-8700-432B-8A97-23AEA478D6EBQ35899571-53689682-5B9E-4EE9-988D-75500C027C1AQ36042046-AA00BA9B-FB67-48C2-85E1-4D91FB43153CQ36074807-5D5BEE91-645B-4EA5-BE72-0BE79CD5DB91Q36395199-0C639D11-BD74-4B40-9C8F-6DAA7C3040ABQ36701732-14DA8BDA-5570-4290-AC69-8C2A6FF9ECCBQ36701828-4E86292D-1FB1-447E-95D8-A7795DFF6B86Q36714026-4BE2B22B-AE3E-4682-B9D6-48DB263E0D72Q36714066-A717CAF1-744E-4D77-85DD-BC782E4184E8Q36721281-B6CD553D-CD40-4451-9B56-D75CEF5C2465Q36733040-8BA45AD1-B3CA-48A1-8CE9-BCF12C85EA74Q36919478-C71702B9-02B9-4616-8347-A617DB9D6E66Q37043226-1D239DA5-7120-455C-9DF6-B8CFD90F7F50Q37050536-CAA6B730-AD92-4E54-B6B3-A917B796F0C4
P2860
Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Atrial fibrillation: current k ...... in epidemiology and genomics.
@ast
Atrial fibrillation: current k ...... in epidemiology and genomics.
@en
type
label
Atrial fibrillation: current k ...... in epidemiology and genomics.
@ast
Atrial fibrillation: current k ...... in epidemiology and genomics.
@en
prefLabel
Atrial fibrillation: current k ...... in epidemiology and genomics.
@ast
Atrial fibrillation: current k ...... in epidemiology and genomics.
@en
P2093
P2860
P50
P1433
P1476
Atrial fibrillation: current k ...... in epidemiology and genomics.
@en
P2093
David D McManus
Jared W Magnani
Moritz F Sinner
Patrick T Ellinor
Steven A Lubitz
P2860
P304
P356
10.1161/CIRCULATIONAHA.111.039677
P407
P577
2011-11-01T00:00:00Z